Monday, October 14, 2013
Craze Work Out Supplement Contains Meth-Like Substance
However, many supplements have hardly been testing and more and more supplements are geared toward energy. One such product, “Craze”, has become popular in a number of countries, but it contains a meth-like ingredient that has some failing drug tests, USA Today reports.
In the United States and South Korea, scientists have conducted some tests; their research of the supplement has shown that a chemical which originally appeared as an illicit designer recreational drug can be found in the product. Despite containing the meth-like ingredients, the makers of Craze, Driven Sports, claim their product is made with only natural ingredients, the article notes.
The scientists began testing Craze after athletes who said they had used the supplement failed several urine drug tests.
“These are basically brand new drugs that are being designed in clandestine laboratories where there’s absolutely no guarantee of quality control,” study co-author Pieter Cohen of Harvard Medical School told the newspaper. “It has never been studied in the human body. Yes, it might make you feel better or have you more pumped up in your workout, but the risks you might be putting your body under of heart attack and stroke are completely unknown.”
Due to the research, Walmart.com and a number of other online retailers stopped selling Craze earlier this year after USA Today reported that tests detected amphetamine-like compounds in the product. However, the work out super-store, GNC, continues to sell Craze in their stores and on other websites.
Driven Sports released a statement in response to the article, “Craze is a legal supplement that provides people with a tool to enhance their workouts, by combining natural extracts to increase their energy. Craze conforms to all U.S. federal regulatory requirements and is proven safe when used as directed. As is the case with any such supplement, the product and its ingredients are subject to regulation by the U.S. Food & Drug Administration.”
The findings appear in the journal Drug Testing and Analysis.